MEMESTRATEGY (02440) announced its annual performance with a net loss attributable to shareholders of 158 million yuan, an increase of 103.46% year-on-year.
Mystery Strategy (02440) announced its full-year performance for the fiscal year ending December 31, 2025. The group's revenue was 58.884 million yuan, a decrease of 40.27% year-on-year; the shareholder's net loss was 158 million yuan, an increase of 103.46% year-on-year; and the loss per share was 48.55 cents.
MEMESTRATEGY (02440) announced the full year performance for the fiscal year ending on December 31, 2025. The Group's revenue was RMB 58.88 million, a decrease of 40.27% year-on-year; the net loss attributable to shareholders was RMB 158 million, an increase of 103.46% year-on-year; the loss per share was 48.55 cents.
Related Articles
VALA (02051) announced its performance in 2025, with adjusted net loss of 98.506 million yuan, an increase of 141.6% year-on-year.
CM-ENERGY (00206) reported annual earnings, with a net profit attributable to shareholders of 1.58 million US dollars, a decrease of 82.75% year-on-year.
SANAI HEALTH GP (01889) issues profit warning, expecting a loss of about 25.5 million to 27.5 million yuan for the year 2025.
VALA (02051) announced its performance in 2025, with adjusted net loss of 98.506 million yuan, an increase of 141.6% year-on-year.
CM-ENERGY (00206) reported annual earnings, with a net profit attributable to shareholders of 1.58 million US dollars, a decrease of 82.75% year-on-year.
SANAI HEALTH GP (01889) issues profit warning, expecting a loss of about 25.5 million to 27.5 million yuan for the year 2025.
RECOMMEND
Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026
Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026
Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026
